FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1363411000001103: Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1899101000001112 Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1899121000001117 Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Is a Bendroflumethiazide 2.5mg tablets 500 tablet true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Is pack of Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has active ingredient Bendroflumethiazide false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has active ingredient Bendrofluazide - chemical false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has AMP Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has specific active ingredient Bendroflumethiazide true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start